SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-001429
Filing Date
2022-05-13
Accepted
2022-05-13 12:14:10
Documents
52
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mtryu-20220331x10q.htm   iXBRL 10-Q 724027
2 EXHIBIT 31.1 mtryu-20220331xex31d1.htm EX-31.1 9698
3 EXHIBIT 31.2 mtryu-20220331xex31d2.htm EX-31.2 9881
4 EXHIBIT 32.1 mtryu-20220331xex32d1.htm EX-32.1 6132
5 EXHIBIT 32.2 mtryu-20220331xex32d2.htm EX-32.2 4733
  Complete submission text file 0001410578-22-001429.txt   3994017

Data Files

Seq Description Document Type Size
6 EX-101.SCH mtryu-20220331.xsd EX-101.SCH 47330
7 EX-101.CAL mtryu-20220331_cal.xml EX-101.CAL 16969
8 EX-101.DEF mtryu-20220331_def.xml EX-101.DEF 186816
9 EX-101.LAB mtryu-20220331_lab.xml EX-101.LAB 310664
10 EX-101.PRE mtryu-20220331_pre.xml EX-101.PRE 270655
46 EXTRACTED XBRL INSTANCE DOCUMENT mtryu-20220331x10q_htm.xml XML 538792
Mailing Address 17 STATE STREET 21ST FLOOR NEW YORK NY 10004
Business Address 17 STATE STREET 21ST FLOOR NEW YORK NY 10004 917-267-0216
Monterey Bio Acquisition Corp (Filer) CIK: 0001860663 (see all company filings)

IRS No.: 852204842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40861 | Film No.: 22921257
SIC: 6770 Blank Checks